EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cerebrospinal fluid sulfatide isoforms lack diagnostic utility in separating progressive from relapsing-remitting multiple sclerosis

Lenka Novakova, Marcus Henricsson, Elias Björnson, Markus Axelsson, Jan Borén, Igal Rosenstein, Jan Lycke, Susanna L Cardell, Maria Blomqvist

Multiple Sclerosis and Related Disorders · 2023

DOI: 10.1016/j.msard.2023.104705 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Multiple Sclerosis and Related Disorders, 2023. Verfasst von Lenka Novakova und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Multiple Sclerosis, Chronic Progressive. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Multiple sclerosis (MS) is an immune-mediated demyelinating disorder of the central nervous system. The glycosphingolipid sulfatide, a lipid particularly enriched in the myelin sheath, has been shown to be involved the maintenance of this specific membrane structure. Sulfatide in cerebrospinal fluid (CSF) may reflect demyelination, a dominating feature of MS. We investigated the diagnostic utility of CSF sulfatide isoform levels to separate different courses or phenotypes of MS disease. MATERIAL AND METHODS: This was a mono-center, cross-sectional study of relapsing-remitting MS (RRMS) (n = 45) and progressive MS (PMS) (n = 42) patients (consisting of primary PMS (n = 17) and secondary PMS (n = 25)) and healthy controls (n = 19). In total, 20 sulfatide isoforms were measured in CSF by liquid chromatography-mass spectrometry. RESULTS: CSF total sulfatide concentrations, as well as CSF sulfatide isoform distribution, did not differ across the study groups, and their levels were independent of disease course/phenotype, disease duration, time to conversion to secondary PMS, age, and disability in MS patients. CONCLUSION: CSF sulfatide isoforms lack diagnostic and prognostic utility as a biomarker for progressive MS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple Sclerosis, Relapsing-RemittingMultiple SclerosisMultiple Sclerosis, Chronic ProgressiveHumansSulfoglycosphingolipidsCross-Sectional StudiesBiomarkersProtein Isoforms

Stichwörter der Autor:innen

BiomarkersCerebrospinal fluidMass spectrometryMultiple sclerosisSulfatide

Substanzen

SulfoglycosphingolipidsBiomarkersProtein Isoforms

Autor:innen und Institutionen

  • Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Department of Molecular and Clinical Medicine/Wallenberg Lab, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Department of Laboratory Medicine, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden; Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg 413 85, Sweden. Electronic address…

Zitieren

APA

Novakova, L., Henricsson, M., Björnson, E., Axelsson, M., Borén, J., Rosenstein, I., Lycke, J., Cardell, S. L., & Blomqvist, M. (2023). Cerebrospinal fluid sulfatide isoforms lack diagnostic utility in separating progressive from relapsing-remitting multiple sclerosis. Multiple Sclerosis and Related Disorders. https://doi.org/10.1016/j.msard.2023.104705

Vancouver

Novakova L, Henricsson M, Björnson E, Axelsson M, Borén J, Rosenstein I, et al. Cerebrospinal fluid sulfatide isoforms lack diagnostic utility in separating progressive from relapsing-remitting multiple sclerosis. Multiple Sclerosis and Related Disorders. 2023. doi:10.1016/j.msard.2023.104705

BibTeX
@article{Novakova2023,
  author = {Novakova, Lenka and Henricsson, Marcus and Björnson, Elias and Axelsson, Markus and Borén, Jan and Rosenstein, Igal and Lycke, Jan and Cardell, Susanna L and Blomqvist, Maria},
  title = {Cerebrospinal fluid sulfatide isoforms lack diagnostic utility in separating progressive from relapsing-remitting multiple sclerosis},
  journal = {Multiple Sclerosis and Related Disorders},
  year = {2023},
  doi = {10.1016/j.msard.2023.104705}
}
Kostenlos starten →